AlveoliX AG

We want to make organs-on-chip technology the new standard for preclinical decision-making and bring data from bench to clinic.

AlveoliX AG develops organ-on-chip technologies and in-vitro models to improve preclinical decision-making and reduce drug development costs.

Partnerships

 

  

  

 

  

  

 

  

  

Clients